NYT Letters To Editor Discuss Antibiotic Research, Development

New York Times: Letters to the Editor: Making Sure Our Antibiotics Remain Potent
Jay Markowitz, senior vice president at Regeneron; Mark Kessel, chair of the Foundation for Innovative New Diagnostics; and Curtis Morris, campaign associate at U.S. PIRG

In these letters to the editor, readers respond to the article, “Crisis Looms in Antibiotics as Drug Makers Go Bankrupt,” first published in the New York Times on December 26, 2019, and “suggest ways to encourage the development of new drugs and prolong the effectiveness of the ones we have” (1/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.